Market News

Wells Fargo analyst Zachary Fadem maintains Texas Roadhouse (NASDAQ:TXRH) with a Overweight and lowers the price target from $230 to $220.

Obsidian Therapeutics, Inc. (NASDAQ:OBX), a clinical-stage biopharmaceutical company harnessing novel protein-regulation technology to develop enginee...

The decline in technology stocks doesn't represent a sudden deterioration in the outlook for the sector, UBS said in a note.

Keybanc analyst Jackson Ader maintains Akamai Technologies (NASDAQ:AKAM) with a Overweight and lowers the price target from $195 to $175.

AirSculpt Technologies (NASDAQ:AIRS) reported third-quarter financial results on Friday. The transcript from the company’s third-quarter earnings call...

Piper Sandler analyst James Fish reiterates Axon Enterprise (NASDAQ:AXON) with a Overweight and lowers the price target from $561 to $540.

Why yes, it is. Here's the scoop.

Wells Fargo analyst Chris Carey maintains Kimberly-Clark (NASDAQ:KMB) with a Equal-Weight and raises the price target from $100 to $110.

Analysts upgraded Centrus Energy, SiTime, MGE Energy, Steven Madden and Becton Dickinson, with new or higher price targets.

Moderna (NASDAQ:MRNA) reported third-quarter financial results on Friday. The transcript from the company’s third-quarter earnings call has been provi...

Companhia De Saneamento (NYSE:SBS) reported third-quarter financial results on Friday. The transcript from the company’s third-quarter earnings call h...

Starfighters Space, Inc. ("Starfighters" or the "Company") (NYSE American: FJET), the space company operating the world's only com...

Wells Fargo analyst Chris Carey maintains Monster Beverage (NASDAQ:MNST) with a Overweight and raises the price target from $50 to $52.

Ready Capital (NYSE:RC) reported third-quarter financial results on Friday. The transcript from the company’s third-quarter earnings call has been pro...

Target stock is upgraded to "Hold" given its improving financials, sales growth, cost cuts, AI initiatives, and debt reduction. Learn more.

Wells Fargo analyst Trey Bowers maintains Wynn Resorts (NASDAQ:WYNN) with a Overweight and lowers the price target from $125 to $122.

StoneX analyst Robert Wasserman maintains Intensity Therapeutics (NASDAQ:INTS) with a Speculative Buy and lowers the price target from $12 to $8.

Applications include motor drives, solar inverters, battery management systems (BMS), servers, IT and industrial infrastructures, and high-voltage DC-...

Blue Owl Capital is rated a 'Strong Buy' due to robust asset quality, strong dividend coverage, and a 24% discount to NAV. Read more on OBDC stock her...